In the event of agreement within the coordination group, referred to by the Director General of the Agence nationale de sécurité du médicament et des produits de santé or by another State :
1° In the case provided for in Article R. 5121-51-1, the Director General of the Agency will notify the States concerned and the marketing authorisation holder of the agreement. In accordance with the assessment report thus approved, the Director General amends or withdraws, as appropriate, the marketing authorisation within thirty days of this notification.
2° In the case provided for in 1° of Article R. 5121-51-3, the Director General of the Agency notifies the States concerned and the applicant of the agreement. In accordance with the approved assessment report, he grants or refuses the marketing authorisation within thirty days of this notification.
3° In the cases provided for in Article R. 5121-51-2 and 2° of Article R. 5121-51-3, the Director General of the Agency grants or refuses the marketing authorisation in accordance with the assessment report thus approved within thirty days of notification of the agreement by the reference State.